Dynorphin Peptides: Antagonists of Melanocortin Receptors (original) (raw)

Abstract

Purpose. To identify possible targets that mediate the non-opioid effects of dynorphin A (DynA), effects that include inflammation and aggravation of traumatic nerve injury.

Methods. We examined dynorphin peptides for functional interaction with the closely related melanocortin (MC) system.

Results. DynA-(l-13)NH2 and other related opioid dynorphin peptides antagonize the human MC1, MC3 and MC4 receptors, and an amphibian MC receptor, with dissociation constants (Kd's) of 40 to 150 nM. The affinity of dynorphin's interaction with MC receptors is therefore greater than with other previously proposed non-opioid targets of dynorphin, which require micromolar concentrations. Dynorphin also antagonizes the adrenocorticotropic hormone (ACTH; MC2) receptor and an MC-like receptor endogenous to COS-7 cells, but with lower efficacy. In contrast DynA had no effect on seven control receptors and was only weakly effective at two others. Metabolites of dynorphin derived from cleavage of the amino terminal Tyr residue, such as DynA(2-17), lack opioid activity yet still produce a number of well established non-opioid effects. These des-Tyr derivatives also antagonized each of the five MC receptors examined.

Conclusions. DynA peptides were found to antagonize MC receptors_in vitro_ with potencies that parallel those reported for pharmacological non-opioid effects of dynorphins in vivo. The combination of DynA and its active metabolites may reach levels sufficient to inhibit MC receptors physiologically. Dynorphin inhibition of MC receptors could prove to be an example of crosstalk between two distinct yet phylogenetically related neurotransmitter systems.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. L. Stanfa, and A. Dickenson. Inflamm. Res. 44:231–41 (1995).
    PubMed Google Scholar
  2. J. M. Walker, H. C. Moises, D. H. Coy, G. Baldrighi, and H. Akil. Science 218:1136–8 (1982).
    PubMed Google Scholar
  3. H. Akil, S. J. Watson, E. Young, M. E. Lewis, H. Khachaturian, and J. M. Walker. Ann. Rev. Neurosci. 7:223–55 (1984).
    PubMed Google Scholar
  4. R. Poggioli, A. V. Vergoni, and A. Bertolini. Peptides 7:843–8 (1986).
    PubMed Google Scholar
  5. A. I. Faden. J. Neurosci. 12:425–9 (1992).
    PubMed Google Scholar
  6. V. K. Shukla, and S. Lemaire. Trends Pharmacol. Sci. 15:420–4 (1994).
    PubMed Google Scholar
  7. M. Dumont, and S. Lemaire J. Mol. Cell Cardiol. 25:983–91 (1993).
    PubMed Google Scholar
  8. C. Chavkin, I. F. James, and A. Goldstein. Science 215:413–5 (1982).
    PubMed Google Scholar
  9. S. Zhang, and L. Yu. J. Biol. Chem. 270:22772–6 (1995).
    PubMed Google Scholar
  10. M. Miura, A. Inui, K. Sano, N. Ueno, A. Teranishi, Y. Hirosue, M. Nakajima, M. Okita, J. Togami, K. Koshiya, S. Baba, and M. Kasuga. Am. J. Physiol. 267:E702–9 (1994).
    PubMed Google Scholar
  11. W. H. Gispen, J. Buitelaar, V. M. Wiegant, L. Terenius, and D. De Wied. Eur. J. Pharmacol. 39:393–7 (1976).
    PubMed Google Scholar
  12. M. E. Hadley. The Melanotropic Peptides, Vols 1–3, CRC Press Inc., Boca Raton, Florida, 1988.
    Google Scholar
  13. A. N. Eberle. The Melanotropins: Chemistry, Physiology and Mechanism of Action, Karger, Basel, Switzerland, 1988.
    Google Scholar
  14. J. M. Walker, H. C. Moises, D. H. Coy, E. A. Young, S. J. Watson, and H. Akil. Life Sci. 31:1821–4 (1982).
    PubMed Google Scholar
  15. A. E. Takemori, H. H. Loh, and N. M. Lee. J. Pharmacol. Exp. Ther. 266:121–4 (1993).
    PubMed Google Scholar
  16. L. P. Hooke, L. He, and N. M. Lee. J. Pharmacol. Exp. Ther. 273:292–7 (1995).
    PubMed Google Scholar
  17. P. C. Contreras and A. E. Takemori. J. Pharmacol. Exp. Ther. 229:21–6 (1984).
    PubMed Google Scholar
  18. J. I. Szekely, E. Miglecz, Z. Dunai-Kovacs, I. Tarnawa, A. Z. Ronai, L. Graf, and S. Bajusz. Life Sci. 24:1931–8 (1979).
    PubMed Google Scholar
  19. A. Bertolini, S. Guarini, E. Rompianesi, and W. Ferrari. Eur. J. Pharmacol. 130:19–26 (1986).
    PubMed Google Scholar
  20. J. D. Alvaro, J. B. Tatro, J. M. Quillan, M. Fogliano, M. Eisenhard, M. R. Lerner, E. J. Nestler, and R. S. Duman. Mol. Pharm. 50:583–91 (1996).
    Google Scholar
  21. A. Bertolini, S. Guarini, W. Ferrari, and E. Rompianesi. Life Sci. 39:1271–80 (1986).
    Article PubMed Google Scholar
  22. J. M. Quillan and W. Sadée. Pharm. Res. 13:1622–28 (1996).
    Article Google Scholar
  23. A. Daniolos, A. B. Lerner, and M. R. Lerner. Pigment Cell Res. 3:38–43 (1990).
    PubMed Google Scholar
  24. J. M. Quillan, C. K. Jayawickreme, and M. R. Lerner. Proc. Natl. Acad. Sci. (USA) 92:2894–98 (1995).
    Google Scholar
  25. J. M. Quillan. Development of a Combinatorial Diffusion Assay and Discovery of MSH Receptor Antagonists, UMI, Ann Arbour, Michigan, 1995.
    Google Scholar
  26. G. Weng, F. Yee, P. Michl, D. Reis, and C. Wahlestedt. Mol. Pharmacol. 48:9–14 (1995).
    PubMed Google Scholar
  27. W. E. Polgar, C. M. Bitler, and L. Toll. Life Sci. 58:1223–9 (1996).
    Article PubMed Google Scholar
  28. L. Chen, Y. Gu, and L. Y. Huang. J. Neurosci. 15:4602–11 (1995).
    PubMed Google Scholar
  29. J. M. Walker, G. G. Berntson, C. A. Sandman, A. J. Kastin, and H. Akil. Eur. J. Pharmacol. 69:71–9 (1981).
    Article PubMed Google Scholar
  30. P. C. Datta, C. A. Sandman, and F. K. Hoehler. Peptides 3:433–7 (1982).
    Article PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California Medical Center, San Francisco, California, 94143-0446
    J. Mark Quillan & Wolfgang Sadée

Authors

  1. J. Mark Quillan
  2. Wolfgang Sadée

Rights and permissions

About this article

Cite this article

Quillan, J.M., Sadée, W. Dynorphin Peptides: Antagonists of Melanocortin Receptors.Pharm Res 14, 713–719 (1997). https://doi.org/10.1023/A:1012185919153

Download citation